Search results
Intravascular Imaging on Calcium
Author(s):
Doosup Shin
,
Sarah Malik
,
Mandeep Singh
,
et al
Added:
7 months ago
Review Article
Author(s):
Nicolas M Van Mieghem
Added:
1 week ago
EuroPCR 2026 — Professor Nicolas Van Mieghem joins us to discuss the FRACTURE trial, which evaluated the safety and effectiveness of the laser-based Seismic intravascular lithotripsy (IVL) system for the treatment of severely calcified coronary lesions.The FRACTURE trial was designed to support both FDA IDE and CE mark regulatory approval. It prospectively enrolled 440 patients, with a primary…
View more
IVUS123 workflow for PCI
Author(s):
Simon J Walsh
,
Rafael Cavalcante
,
Kevin Croce
,
et al
Added:
4 months ago
Review Article
Author(s):
Matthias Bossard
Added:
7 months ago
TCT 2025 - The randomized VICTORY Study finds OCT-guided PCI involving lesion preparation with the OPN super-high-pressure non-compliant balloon is non-inferior to intravascular lithotropsy.Dr Matthias Bossard (Kantonsspital Lucerne, Lucerne, CH) joins us to discuss findings from the VICTORY Trial, a randomized, multicenter, non-inferiority comparison evaluating intravascular lithotripsy versus…
View more
Getting More from IVL Technology
Author(s):
Anirban Choudhury
,
Majd B Protty
,
Hussain Hussain
,
et al
Added:
6 months ago
Expert Opinion
Has the Pressure Wire Had its Day?
Author(s):
Bhavik Modi
,
Subhabrata Dutta
,
Damien Collison
,
et al
Added:
1 year ago
Point-Counterpoint
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
2 years ago
What's hot at EuroPCR 2024?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.What is the potential impact of the new data on practice? What details should we look out for? What is the context of the EuroPCR trials?Trials covered included:00…
View more
Author(s):
Nicolas M Van Mieghem
Added:
4 weeks ago
In this EuroPCR 2026 preview, Prof Nicolas Van Mieghem (Erasmus University, NL) walks through the most anticipated late-breaking trials across calcified coronary disease, structural heart intervention, and mechanical support — from laser-based IVL and atherectomy comparisons to three-year TAVI outcomes, tricuspid repair, high-risk PCI, and pulmonary embolism therapy.Editor: Mirjam Boros
View more
Stéphane G Carlier
Research Area(s) / Expertise:
Author
Expertise
Author(s):
Suzanne J Baron
Added:
7 months ago
TCT 2025 — Dr Suzanne J Baron (Massachusetts General Hospital, US), principal investigator of the Short-CUT trial (NCT06089135; Baim Institute for Clinical Research), joins us to discuss this investigator-initiated, multicentre randomized controlled study.The trial enrolled 410 patients with moderate to severe coronary artery calcification across up to 22 international sites. Eligible…
View more